Evidence map›Paper›PMID 41172464›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2025

Diagnosis, treatment, and management of mediastinal masses.

Kubra Nur Kilic, Omer Topaloglu, Sami Karapolat, Atila Turkyilmaz, Ali Akdogan, Celal Tekinbas

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kubra Nur KilicKaradeniz Technical University, Faculty of Medicine, Department of Thoracic Surgery - Trabzon, Turkey.ORCID http://orcid.org/0000-0002-8867-0839
Omer TopalogluRecep Tayyip Erdogan University, Faculty of Medicine, Department of Thoracic Surgery - Rize, Turkey.ORCID http://orcid.org/0000-0001-5652-6018
Sami KarapolatKaradeniz Technical University, Faculty of Medicine, Department of Thoracic Surgery - Trabzon, Turkey.ORCID http://orcid.org/0000-0001-8309-5348
Atila TurkyilmazKaradeniz Technical University, Faculty of Medicine, Department of Thoracic Surgery - Trabzon, Turkey.ORCID http://orcid.org/0000-0002-4827-7469
Ali AkdoganKaradeniz Technical University, Faculty of Medicine, Department of Anesthesiology - Trabzon, Turkey.ORCID http://orcid.org/0000-0001-7592-3844
Celal TekinbasKaradeniz Technical University, Faculty of Medicine, Department of Thoracic Surgery - Trabzon, Turkey.ORCID http://orcid.org/0000-0001-9361-9483

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMediastinal neoplasms are relatively rare tumors that require surgical or non-surgical treatment, and they harbor a wide variety of cell types. The aim of this study was to evaluate the surgical outcomes and prognosis of patients who underwent surgery for mediastinal masses.

methodsThe age, gender, symptoms, comorbid factors, radiological findings, preoperative diagnostic steps, surgical procedure, mortality, complications, length of hospital stay, histopathological diagnosis, and survival of 118 patients with mediastinal masses operated on for diagnosis and treatment between January 2013 and December 2018 were retrospectively analyzed.

resultsWhen the mediastinal masses were evaluated according to compartments, the most common mass was found in the anterior mediastinum (n=72, 61%). While 83.3% of malignant lesions were located in the anterior mediastinum, no malignant lesion was detected in the posterior mediastinum. There was a significant correlation between the compartment where the mass was located and its malignancy. A significant increase in the malignancy rate was observed among male patients. The likelihood of malignancy increased with increasing tumor size (p=0.002). Complications were shown to significantly extend the length of hospitalization (p=0.018). Overall survival was found to be at an average of 71.46±2.1 months. The 5-year survival rate was found to be 88.1%. There was a significant difference in survival between genders, in favor of the female sex (p=0.02).

conclusionConsidering the low morbidity and mortality rates of mediastinal masses, surgical intervention should be performed promptly for the diagnosis and treatment of mediastinal masses. With videothoracoscopy, adequate biopsies can be obtained from unresectable masses and complete excision of benign lesions can be achieved safely.

Indexed as

Mediastinal NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleHumansLength of StayMaleMiddle AgedPrognosisRetrospective StudiesSex FactorsSurvival RateTreatment OutcomeYoung Adult

Identifiers

PMID41172464
PMCPMC12571419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.